Lisa Y Law (Lisa Law)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 16

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Newly Diagnosed

Top Venues

Leukemia & lymphoma

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Clinical case reports

This page only lists publications with an associated author ORCID identifier.

Publications

Helen W Wong, Vivian H Nguyen, Timothy Y Mok, Fang Niu, Merta Cushing, Michael Lam, Stephanie L Ho, Lisa Y Law, Ashraf R Aziz, Rita L Hui
Outcomes of Rituximab-abbs versus Rituximab in Patients with Diffuse Large B-Cell Lymphoma in a Noninferiority Study. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
Mini Kamboj, Kari Bohlke, Deana M Baptiste, Kieron Dunleavy, Abbey Fueger, Lee Jones, Amar H Kelkar, Lisa Y Law, Kristine B LeFebvre, Qamar-Un-Nisa Chaudhry, Eric D Miller, Larissa A Meyer, Heather B Moore, Heloisa P Soares, Randy A Taplitz, Edom Seife Woldetsadik, Elise C Kohn
Vaccination of Adults With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Mini Kamboj, Kari Bohlke, Deana M Baptiste, Kieron Dunleavy, Abbey Fueger, Lee Jones, Amar H Kelkar, Lisa Y Law, Kristine B LeFebvre, Qamar-Un-Nisa Chaudhry, Eric D Miller, Larissa A Meyer, Heather B Moore, Heloisa P Soares, Randy A Taplitz, Edom Seife Woldetsadik, Elise C Kohn
Vaccination of Adults With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Mini Kamboj, Kari Bohlke, Deana M Baptiste, Kieron Dunleavy, Abbey Fueger, Lee Jones, Amar H Kelkar, Lisa Y Law, Kristine B LeFebvre, Qamar-Un-Nisa Chaudhry, Eric D Miller, Larissa A Meyer, Heather B Moore, Heloisa P Soares, Randy A Taplitz, Edom Seife Woldetsadik, Elise C Kohn
Vaccination of Adults With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Helen W Wong, Vivian H Nguyen, Timothy Y Mok, Fang Niu, Merta Cushing, Michael Lam, Stephanie L Ho, Lisa Y Law, Ashraf R Aziz, Rita L Hui
Outcomes of Rituximab-abbs versus Rituximab in Patients with Diffuse Large B-Cell Lymphoma in a Noninferiority Study. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)
Mini Kamboj, Kari Bohlke, Deana M Baptiste, Kieron Dunleavy, Abbey Fueger, Lee Jones, Amar H Kelkar, Lisa Y Law, Kristine B LeFebvre, Qamar-Un-Nisa Chaudhry, Eric D Miller, Larissa A Meyer, Heather B Moore, Heloisa P Soares, Randy A Taplitz, Edom Seife Woldetsadik, Elise C Kohn
Vaccination of Adults With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Mini Kamboj, Kari Bohlke, Deana M Baptiste, Kieron Dunleavy, Abbey Fueger, Lee Jones, Amar H Kelkar, Lisa Y Law, Kristine B LeFebvre, Qamar-Un-Nisa Chaudhry, Eric D Miller, Larissa A Meyer, Heather B Moore, Heloisa P Soares, Randy A Taplitz, Edom Seife Woldetsadik, Elise C Kohn
Vaccination of Adults With Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (14) (2024)
Helen W Wong, Vivian H Nguyen, Timothy Y Mok, Fang Niu, Merta Cushing, Michael Lam, Stephanie L Ho, Lisa Y Law, Ashraf R Aziz, Rita L Hui
Outcomes of Rituximab-abbs versus Rituximab in Patients with Diffuse Large B-Cell Lymphoma in a Noninferiority Study. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (4) (2024)
Sarit Assouline, Laura C Michaelis, Megan Othus, Annette E Hay, Roland B Walter, Meagan A Jacoby, Mark A Schroeder, Geoffrey L Uy, Lisa Y Law, Faisal Cheema, Kendra L Sweet, Adam S Asch, Jijun Jane Liu, Anna B Moseley, Tracy Maher, Laura L Kingsbury, Min Fang, Jerald Radich, Richard F Little, Harry P Erba
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612. Leukemia & lymphoma 64 (2) (2022)
Sarit Assouline, Laura C Michaelis, Megan Othus, Annette E Hay, Roland B Walter, Meagan A Jacoby, Mark A Schroeder, Geoffrey L Uy, Lisa Y Law, Faisal Cheema, Kendra L Sweet, Adam S Asch, Jijun Jane Liu, Anna B Moseley, Tracy Maher, Laura L Kingsbury, Min Fang, Jerald Radich, Richard F Little, Harry P Erba
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612. Leukemia & lymphoma 64 (2) (2022)
Sarit Assouline, Laura C Michaelis, Megan Othus, Annette E Hay, Roland B Walter, Meagan A Jacoby, Mark A Schroeder, Geoffrey L Uy, Lisa Y Law, Faisal Cheema, Kendra L Sweet, Adam S Asch, Jijun Jane Liu, Anna B Moseley, Tracy Maher, Laura L Kingsbury, Min Fang, Jerald Radich, Richard F Little, Harry P Erba
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612. Leukemia & lymphoma (2022)
Sarit Assouline, Laura C Michaelis, Megan Othus, Annette E Hay, Roland B Walter, Meagan A Jacoby, Mark A Schroeder, Geoffrey L Uy, Lisa Y Law, Faisal Cheema, Kendra L Sweet, Adam S Asch, Jijun Jane Liu, Anna B Moseley, Tracy Maher, Laura L Kingsbury, Min Fang, Jerald Radich, Richard F Little, Harry P Erba
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612. Leukemia & lymphoma (2022)
Sarit Assouline, Laura C Michaelis, Megan Othus, Annette E Hay, Roland B Walter, Meagan A Jacoby, Mark A Schroeder, Geoffrey L Uy, Lisa Y Law, Faisal Cheema, Kendra L Sweet, Adam S Asch, Jijun Jane Liu, Anna B Moseley, Tracy Maher, Laura L Kingsbury, Min Fang, Jerald Radich, Richard F Little, Harry P Erba
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612. Leukemia & lymphoma 64 (2) (2022)
Sarit Assouline, Laura C Michaelis, Megan Othus, Annette E Hay, Roland B Walter, Meagan A Jacoby, Mark A Schroeder, Geoffrey L Uy, Lisa Y Law, Faisal Cheema, Kendra L Sweet, Adam S Asch, Jijun Jane Liu, Anna B Moseley, Tracy Maher, Laura L Kingsbury, Min Fang, Jerald Radich, Richard F Little, Harry P Erba
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612. Leukemia & lymphoma 64 (2) (2022)
Sarit Assouline, Laura C Michaelis, Megan Othus, Annette E Hay, Roland B Walter, Meagan A Jacoby, Mark A Schroeder, Geoffrey L Uy, Lisa Y Law, Faisal Cheema, Kendra L Sweet, Adam S Asch, Jijun Jane Liu, Anna B Moseley, Tracy Maher, Laura L Kingsbury, Min Fang, Jerald Radich, Richard F Little, Harry P Erba
A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612. Leukemia & lymphoma 64 (2) (2022)
Lisa Y Law, Gwendolyn Ho, Dazhi Cen, Jeffrey Stenger
Atypical manifestations of coronavirus disease 2019 (COVID-19)-associated autoimmune thrombotic thrombocytopenic purpura. Clinical case reports 9 (3) (2021)